Integra LifeSciences Holdings Corp (IART) stock
IARTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 9/306% below fair value
$13.86+0.31 (+2.29%)
Close on Nov 18, 2026Market cap $1.08BP/E 81.5Yield –
Integra LifeSciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Integra LifeSciences's revenue for the twelve months ending Sep 30, 2026 was $1.66B, up 0.8% year over year. For fiscal 2025 it was $1.64B, up 1.5% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $1.64B in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.64B | +1.5% |
| FY2024 | Dec 31, 2024 | $1.61B | +4.5% |
| FY2023 | Dec 31, 2023 | $1.54B | -1.0% |
| FY2022 | Dec 31, 2022 | $1.56B | +1.0% |
| FY2021 | Dec 31, 2021 | $1.54B | +12.4% |
| FY2020 | Dec 31, 2020 | $1.37B | -9.6% |
| FY2019 | Dec 31, 2019 | $1.52B | +3.1% |
| FY2018 | Dec 31, 2018 | $1.47B | +23.9% |
| FY2017 | Dec 31, 2017 | $1.19B | +19.8% |
| FY2016 | Dec 31, 2016 | $992.08M | +12.4% |
| FY2015 | Dec 31, 2015 | $882.73M | +10.8% |
| FY2014 | Dec 31, 2014 | $796.72M | +14.3% |
| FY2013 | Dec 31, 2013 | $696.83M | -16.1% |
| FY2012 | Dec 31, 2012 | $830.87M | +6.5% |
| FY2011 | Dec 31, 2011 | $780.08M | +6.6% |
| FY2010 | Dec 31, 2010 | $732.07M | +7.3% |
| FY2009 | Dec 31, 2009 | $682.49M | +4.3% |
| FY2008 | Dec 31, 2008 | $654.60M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $411.18M | +2.3% |
| Q2 FY2026 | Jun 30, 2026 | $418.76M | +0.8% |
| Q1 FY2026 | Mar 31, 2026 | $391.92M | +2.4% |
| Q4 FY2025 | Dec 31, 2025 | $434.93M | -1.7% |
| Q3 FY2025 | Sep 30, 2025 | $402.06M | +5.6% |
| Q2 FY2025 | Jun 30, 2025 | $415.61M | -0.6% |
| Q1 FY2025 | Mar 31, 2025 | $382.65M | +3.7% |
| Q4 FY2024 | Dec 31, 2024 | $442.65M | +11.5% |
| Q3 FY2024 | Sep 30, 2024 | $380.83M | -0.4% |
| Q2 FY2024 | Jun 30, 2024 | $418.18M | +9.7% |
| Q1 FY2024 | Mar 31, 2024 | $368.87M | -3.1% |
| Q4 FY2023 | Dec 31, 2023 | $397.04M | -0.2% |
| Q3 FY2023 | Sep 30, 2023 | $382.42M | -0.7% |
| Q2 FY2023 | Jun 30, 2023 | $381.27M | -4.2% |
| Q1 FY2023 | Mar 31, 2023 | $380.85M | +1.1% |
| Q4 FY2022 | Dec 31, 2022 | $398.02M | -1.8% |
| Q3 FY2022 | Sep 30, 2022 | $385.19M | -0.4% |
| Q2 FY2022 | Jun 30, 2022 | $397.82M | +2.0% |
| Q1 FY2022 | Mar 31, 2022 | $376.64M | +4.6% |
| Q4 FY2021 | Dec 31, 2021 | $405.52M | +4.3% |
| Q3 FY2021 | Sep 30, 2021 | $386.86M | +4.5% |
| Q2 FY2021 | Jun 30, 2021 | $389.99M | +50.8% |
| Q1 FY2021 | Mar 31, 2021 | $360.07M | +1.6% |
| Q4 FY2020 | Dec 31, 2020 | $388.65M | -1.6% |
| Q3 FY2020 | Sep 30, 2020 | $370.23M | -2.3% |
| Q2 FY2020 | Jun 30, 2020 | $258.67M | -32.6% |
| Q1 FY2020 | Mar 31, 2020 | $354.32M | -1.5% |
| Q4 FY2019 | Dec 31, 2019 | $395.13M | +3.1% |
| Q3 FY2019 | Sep 30, 2019 | $379.10M | +3.6% |
| Q2 FY2019 | Jun 30, 2019 | $383.65M | +4.8% |
| Q1 FY2019 | Mar 31, 2019 | $359.69M | +0.7% |
| Q4 FY2018 | Dec 31, 2018 | $383.32M | +4.0% |
| Q3 FY2018 | Sep 30, 2018 | $365.85M | +31.2% |
| Q2 FY2018 | Jun 30, 2018 | $366.19M | +29.8% |
| Q1 FY2018 | Mar 31, 2018 | $357.08M | +38.1% |
| Q4 FY2017 | Dec 31, 2017 | $368.60M | +44.2% |
| Q3 FY2017 | Sep 30, 2017 | $278.83M | – |
| Q2 FY2017 | Jun 30, 2017 | $282.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $258.64M | – |
| Q4 FY2016 | Dec 31, 2016 | $255.66M | – |
See a number that looks wrong?